Danimer Scientific, Inc. (DNMR) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DNMR representa a Danimer Scientific, Inc., una empresa del sector Basic Materials con un precio de $ (capitalización de mercado 0). Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Danimer Scientific, Inc. (DNMR) Exposición a Materiales y Productos Básicos
Danimer Scientific, Inc. specializes in developing and producing biodegradable plastic alternatives, primarily polyhydroxyalkanoate (PHA) under the Nodax brand. Targeting consumer packaging and plastics industries, the company offers sustainable solutions to replace traditional petroleum-based plastics, addressing growing environmental concerns and regulatory pressures.
Tesis de Inversión
Danimer Scientific presents an investment opportunity within the burgeoning bioplastics market, driven by increasing consumer demand for sustainable packaging and stricter environmental regulations. The company's Nodax PHA offers a biodegradable alternative to traditional plastics, potentially capturing market share as brands seek eco-friendly solutions. However, current financials reveal a negative profit margin of -333.0% and a negative gross margin of -57.7%, indicating significant challenges in achieving profitability. The company's success hinges on scaling production efficiently, securing key partnerships with major consumer brands, and navigating the competitive landscape of bioplastic producers. Investors should closely monitor the company's progress in improving margins and achieving sustainable revenue growth.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Danimer Scientific operates in the bioplastics market, addressing the increasing demand for sustainable alternatives to traditional petroleum-based plastics.
- The company's core product, Nodax PHA, is a biodegradable plastic feedstock used in various applications, including films, straws, and food containers.
- Danimer Scientific serves consumer packaging brand owners, converters, and manufacturers in the plastics industry.
- The company's negative profit margin of -333.0% and gross margin of -57.7% highlight the current challenges in achieving profitability.
- Danimer Scientific's beta of 1.63 suggests higher volatility compared to the overall market.
Competidores y Pares
Fortalezas
- Proprietary Nodax PHA technology.
- Focus on biodegradable and sustainable materials.
- Potential for strong growth in the bioplastics market.
- Established relationships with consumer packaging companies.
Debilidades
- Negative profit and gross margins.
- Limited production capacity compared to larger competitors.
- Reliance on a few key customers.
- Higher production costs compared to traditional plastics.
Catalizadores
- Ongoing: Increasing consumer demand for sustainable packaging solutions.
- Ongoing: Government regulations promoting the use of bioplastics.
- Upcoming: Potential partnerships with major consumer brands to adopt Nodax PHA.
- Ongoing: Expansion of production capacity to meet growing demand.
- Ongoing: Development of new applications for PHA in various industries.
Riesgos
- Ongoing: Negative profit and gross margins indicating financial instability.
- Potential: Competition from established chemical companies with greater resources.
- Potential: Fluctuations in raw material prices impacting production costs.
- Potential: Technological advancements in alternative materials.
- Potential: Limited liquidity due to trading on the OTC market.
Oportunidades de crecimiento
- Growth opportunity 1: Expanding Production Capacity: Danimer Scientific can increase its market share by expanding its production capacity to meet the growing demand for PHA. Investing in new manufacturing facilities and optimizing existing processes will enable the company to fulfill larger orders and secure long-term contracts with major consumer brands. The bioplastics market is projected to reach $29.7 billion by 2025, providing a substantial opportunity for Danimer Scientific to capitalize on increased production capabilities.
- Growth opportunity 2: Strategic Partnerships: Forming strategic partnerships with consumer packaging companies and manufacturers can accelerate the adoption of Nodax PHA. Collaborating with established players in the plastics industry will provide Danimer Scientific with access to existing distribution channels and customer networks. These partnerships can also facilitate the development of new applications for PHA and drive innovation in sustainable packaging solutions. Timeline: Ongoing.
- Growth opportunity 3: New Product Development: Investing in research and development to create new biopolymer formulations and applications can differentiate Danimer Scientific from its competitors. Developing PHA-based solutions for specific industries, such as agriculture or healthcare, can open up new market segments and revenue streams. Focusing on developing high-performance bioplastics with enhanced properties will further strengthen the company's competitive advantage. Timeline: Ongoing.
- Growth opportunity 4: Government Incentives and Regulations: Capitalizing on government incentives and regulations that promote the use of bioplastics can drive demand for Danimer Scientific's products. Many countries are implementing policies to reduce plastic waste and encourage the adoption of sustainable alternatives. By actively engaging with policymakers and participating in industry initiatives, Danimer Scientific can benefit from these favorable regulatory trends. Timeline: Ongoing.
- Growth opportunity 5: Global Expansion: Expanding into new geographic markets can diversify Danimer Scientific's revenue base and reduce its reliance on the North American market. Targeting regions with strong environmental awareness and supportive government policies, such as Europe and Asia, can provide significant growth opportunities. Establishing local partnerships and distribution networks in these regions will facilitate market entry and ensure long-term success. Timeline: Ongoing.
Oportunidades
- Expanding production capacity to meet growing demand.
- Forming strategic partnerships with major consumer brands.
- Developing new applications for PHA in various industries.
- Benefiting from government incentives and regulations promoting bioplastics.
Amenazas
- Competition from established chemical companies.
- Fluctuations in raw material prices.
- Technological advancements in alternative materials.
- Economic downturns affecting consumer spending.
Ventajas competitivas
- Proprietary Nodax PHA technology offers a biodegradable alternative to traditional plastics.
- Focus on sustainable bioplastic solutions aligns with growing environmental concerns.
- Established relationships with consumer packaging companies.
- Potential for economies of scale as production volume increases.
Acerca de DNMR
Founded in 2004 and headquartered in Bainbridge, Georgia, Danimer Scientific, Inc. is a performance polymer company focused on creating sustainable bioplastic replacements for conventional petroleum-based plastics. The company's core product is polyhydroxyalkanoate (PHA), a biodegradable plastic feedstock alternative marketed under the Nodax brand. This material is utilized in a wide array of plastic applications, including films, straws, food containers, and other packaging solutions. In addition to PHA, Danimer Scientific also produces polylactic acid-based resins for coating disposable paper cups and other biopolymers. The company offers its biopolymers in various forms, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. Danimer Scientific markets its products directly to consumer packaging brand owners, converters, and manufacturers within the plastics industry, positioning itself as a key player in the growing market for sustainable and biodegradable plastic alternatives.
Qué hacen
- Develops bioplastic replacements for traditional petroleum-based plastics.
- Produces polyhydroxyalkanoate (PHA) under the Nodax brand.
- Offers PHA for various plastic applications like films, straws, and food containers.
- Produces polylactic acid-based resins for coating disposable paper cups.
- Provides biopolymers in forms like additives, coatings, fibers, and films.
- Markets products to consumer packaging brand owners and manufacturers.
Modelo de Negocio
- Develops and manufactures bioplastic materials.
- Sells biopolymers to consumer packaging companies.
- Generates revenue through direct sales and partnerships.
- Focuses on sustainable and biodegradable plastic alternatives.
Contexto de la Industria
Danimer Scientific operates within the specialty chemicals industry, specifically targeting the bioplastics market. This market is driven by increasing consumer awareness of environmental issues and stricter regulations on single-use plastics. The competitive landscape includes companies like CDELF, ETUGF, GFTRF, GSPI, and HANCF, each offering various bioplastic solutions. The demand for biodegradable and compostable materials is expected to grow, creating opportunities for companies like Danimer Scientific to expand their market share by offering innovative and cost-effective bioplastic alternatives.
Clientes Clave
- Consumer packaging brand owners seeking sustainable materials.
- Converters who transform raw materials into finished products.
- Manufacturers in the plastics industry looking for bioplastic alternatives.
Finanzas
Gráfico e información
Precio de la acción de Danimer Scientific, Inc. (DNMR): Price data unavailable
Últimas noticias
-
Earnings Scheduled For November 14, 2024
benzinga · 14 nov 2024
-
Earnings Scheduled For November 14, 2023
benzinga · 14 nov 2023
-
Stocks That Hit 52-Week Lows On Monday
benzinga · 12 dic 2022
-
Stocks That Hit 52-Week Lows On Monday
benzinga · 24 oct 2022
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DNMR.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para DNMR.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de DNMR en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Richard N. Altice
CEO
Richard N. Altice serves as the CEO of Danimer Scientific, Inc. His background includes extensive experience in the chemicals and plastics industries. He has held various leadership positions in both public and private companies, focusing on strategic planning, business development, and operational efficiency. Altice's expertise lies in driving growth and innovation within the sustainable materials sector. His leadership is crucial for Danimer Scientific as the company navigates the evolving bioplastics market.
Historial: Under Richard N. Altice's leadership, Danimer Scientific has focused on expanding its production capabilities and forging partnerships with key players in the consumer packaging industry. He has overseen the commercialization of Nodax PHA and its adoption in various applications. A key milestone has been navigating the company through a challenging financial period while maintaining focus on long-term growth and sustainability goals.
Información del mercado OTC de DNMR
The OTC Other tier represents the lowest tier of the OTC market, indicating that Danimer Scientific may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as those listed on major exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume can lead to price volatility and difficulty in executing trades.
- OTC Other tier companies may be subject to less regulatory oversight.
- Potential for fraud or manipulation is higher in the OTC market.
- Limited access to company information and management.
- Verify the company's registration and legal standing.
- Attempt to obtain any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC securities.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory actions or legal disputes involving the company.
- Company has a functional website with contact information.
- Company has been in operation for a reasonable period of time (founded in 2004).
- Company has a physical headquarters in Bainbridge, Georgia.
- Company has a stated business purpose and target market.
- Company has a CEO and management team.
Acciones de Danimer Scientific, Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar DNMR?
Danimer Scientific, Inc. (DNMR) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Proprietary Nodax PHA technology.. Riesgo principal a monitorear: Ongoing: Negative profit and gross margins indicating financial instability.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de DNMR?
DNMR actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de DNMR?
Los precios de DNMR se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre DNMR?
La cobertura de analistas para DNMR incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en DNMR?
Las categorías de riesgo para DNMR incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Negative profit and gross margins indicating financial instability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de DNMR?
La relación P/E para DNMR compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está DNMR sobrevalorada o infravalorada?
Determinar si Danimer Scientific, Inc. (DNMR) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de DNMR?
Danimer Scientific, Inc. (DNMR) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on the most recent available information.
- OTC market data may be limited and subject to change.